The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1576
ISSUE1576
July 15, 2019
Benzhydrocodone/Acetaminophen (Apadaz) for Pain
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Benzhydrocodone/Acetaminophen (Apadaz) for Pain
July 15, 2019 (Issue: 1576)
The FDA has approved Apadaz (KemPharm), a short-acting,
fixed-dose combination of benzhydrocodone
and acetaminophen, for short-term management
(≤14 days) of acute pain severe enough to require an
opioid and for which alternative treatment...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.